Christopher Aiken

HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication. Read More

Vanderbilt researchers are discovering ways that host proteins block HIV-1 infection, which could suggest new avenues for treatment. Read More

(photo by Anne Rayner) The Rockefeller University’s Paul Bieniasz, Ph.D., center, here with Vanderbilt’s Samuel Santoro, Ph.D., left, and Christopher Aiken, Ph.D., discussed his research on retroviruses at his recent Flexner Discovery Lecture, which was sponsored by the Department of Pathology, Microbiology and Immunology. Read More

The extraordinary achievements of nine Vanderbilt endowed chair holders were lauded at a Sept. 8 celebration during which generous donors were thanked. Read More

New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target. Read More

Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year. Read More

The 2013 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during Wednesday’s Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Award recipients were nominated by their faculty colleagues and chosen by the Academic Enterprise Faculty Awards Selection Committee. Read More